CURRICULUM VITAE
Edit Olasz MD, PhD
Edit Olasz MD, PhD
Associate Professor
Department of Dermatology
Department of Dermatology
HOME ADDRESS: |
W279N2923 Rocky Point Rd |
Pewaukee, WI 53072 |
Phone: 4146901006 |
OFFICE ADDRESS: |
The Hub for Collaborative Medicine |
8701 Watertown Plank Road |
Milwaukee, WI 53226 |
EDUCATION: |
09/1989 - 08/1995 M.D., University of Szeged, Medical and Medical Sciences Center, Szeged, Hungary |
07/2002 - 12/2004 Ph.D., University of Szeged, Medical and Medical Sciences Center, Szeged, Hungary |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
09/1995 - 08/1997 Resident, Department of Dermatology, University of Szeged, Medical and Medical Sciences Center, Szeged, Hungary |
08/1997 - 10/2001 Postdoctoral Fellow, Dermatology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD |
11/2001 - 06/2004 Senior Research Scientist, Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI |
07/2004 - 06/2005 Intern, Transitional Year, St. Michael's Hospital, Milwaukee, WI |
07/2005 - 06/2008 Resident, Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI |
07/2007 - 06/2008 Chief Resident, Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI |
FACULTY APPOINTMENTS: |
07/2008 - 06/30/2015 Assistant Professor, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
07/01/2015 - Present Associate Professor, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
ADMINISTRATIVE APPOINTMENTS: |
07/01/2010 - 02/01/2020 Chief of Dermatology Section, Medicine, Dermatology Section, Milwaukee VA, WI |
07/01/2011 - 06/31/2016 Global Health Liason, Dermatology, Medical College of Wisconsin |
12/01/2013 - 06/31/2016 Member, Clinical Competency Committee, Dermatology, Medical College of Wisconsin |
07/01/2017 - Present Director of Aesthetic and Laser Clinic, Dermatology, Medical College of Wisconsin, FORME Aesthetic and Vein Center |
05/2023 - Present Faculty Council Representative sub, Dermatology, Medical College of Wisconsin |
EDUCATIONAL ADMINISTRATIVE APPOINTMENTS: |
07/01/2008 - Present Member Resident Curriculum Committee, Surgical Curriculum, Dermatology, Medical College of Wisconsin |
02/01/2014 - 07/01/2018 Member, Clinical Competency Committee, Dermatology, Medical College of Wisconsin |
12/01/2020 - Present Member of Research Committee, Dermatology, Medical College of Wisconsin |
HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS: |
09/01/2008 - 2019 Director, Phototherapy Unit, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
09/01/2008 - Present Director of Cosmetic and Laser Clinic, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
05/01/2009 - 2020 Section Chief, Section of Dermatology, Medicine, VA Hospital, Milwaukee, WI |
09/01/2009 - 2018 Director of Laboratory of Cutaneous Immunopathology, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
RESEARCH ADMINISTRATIVE APPOINTMENTS: |
07/01/2008 - 06/30/2017 Principal Investigator, Dermatology, Medical College of Wisconsin, Milwaukee, WI |
12/01/2020 - Present Member of Research Committee, Dermatology, Medical College of Wisconsin |
HOSPITAL STAFF PRIVILEGES: |
07/01/2008 - Present Dermatology, VA Hospital, Milwaukee, WI |
07/01/2008 - Present Children's Hospital of Wisconsin, Milwaukee, WI |
07/01/2008 - Present Dermatology, Froedtert Hospital, Milwaukee, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Dermatology | 08/07/2009 | 12/31/2019 |
Licensure | Number | Issue Date | Expiration |
Wisconsin medical | 48592-20 | 09/09/2005 | 10/31/2015 |
AWARDS AND HONORS: |
07/01/1993 - 07/31/1994 International Federation for Medical Students' Association Scholarship, Department of Surgery, Son Duretta Hospital, Palma de Mallorca, Mallorca, International Federation for Medical Students' Association |
12/01/1993 - 12/21/1993 Hungarian-German Research Fellowship, Department of Dermatology, Ludwig Maximillian University Munich, Hungarian Academy of Science |
09/1994 Pro Cultura Renovanda Hungariae Students for the Science Research Grant, University of Szeged |
09/01/1996 - 10/15/1996 German-Hungarian Joint Research Fellowship, Phototherapy Unit of the Department of Dermatology, Heinrich-Heine University, Duesseldorf, Hungarian Academy of Science |
09/1996 European Society for Dermatological Research Travel Award, European Society for Dermatological Research |
1996 - Present Best Clinical Presentation Award, Annual Meeting of the Young Hungarian Dermatologists |
03/1997 Registration Scholarship of the American Academy of Dermatology Committee on International Affairs, 55th Annual Meeting of the AAD in San Francisco, American Academy of Dermatology |
04/2000 Best Poster Award, NIH Annual Immunology Retreat, Arlie, National Institutes of Health |
04/01/2008 - 04/21/2008 Women's Dermatological Society Mentorship Award, Chemoprevention of skin cancer in solid organ transplant patients, Charite Hospital, Berlin, Women's Dermatological Society |
06/01/2009 - 07/31/2009 Mentee, Tim Chang, medical student summer research stipend award, National Cancer Institute |
07/01/2009 - 06/30/2010 American Academy of Dermatology Leadership Program, Mentee, American Academy of Dermatology |
03/01/2017 - 03/01/2018 American Academy of Dermatology Leadership Program, Mentor, American Academy of Dermatology |
09/01/2018 - 09/01/2019 Future Leaders Network Mentor, American Society of Dermatologic Surgery |
2020 - Present Best Doctors, Dermatology, Milwaukee Best Doctors |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
1997 - Present Society for Investigative Dermatology (member) |
09/01/2005 - 09/01/2009 European Society for Dermatological Research (member) |
2005 - Present American Academy of Dermatology (fellow) |
2005 - Present Dermatology Foundation (member) |
2007 - 2009 International Society of Dermatology (member) |
2007 - 2022 Women's Dermatological Society (member) |
2008 - Present American Society of Dermatologic Surgeons (member) |
2008 - Present International Transplant Skin Cancer Collaborative (member) |
2013 - 2023 Wisconsin Dermatological Society (Representative for AAD Advisory Board) |
2021 - Present Association of American Cosmetic Dermatologist (Co-Chair Research Committee) |
2022 - Present American Society of Laser Medicine and Surgery (Collaborate Research Task Force member) |
2022 - Present International Peel Society |
2023 - Present Magyar Dermatologia Tarsulat (Founding Member of the Hungarian American Section) |
EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS: |
Editorial Board |
2013 - Present The Journal of Clinical and Aesthetic Dermatology |
Journal Review |
British Journal of Dermatology |
Archives of Dermatology |
Journal of Investigative Dermatology |
Journal of the American Academy of Dermatology |
Clinical and Experimental Dermatology |
Journal of Cosmetic Dermatology |
Ad-Hoc Reviewer |
2017 - Present Archives of Dermatology |
2021 - Present Photodermatology, Photoimmunology & Photomedicine |
LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
2010 - 2016 Departmental Liaison, Medical College of Wisconsin, Global Health Committee |
02/01/2014 - 2016 Surgical Competency Director, Clinical Competency Committee, Department of Dermatology, Medical College of Wisconsin |
10/01/2016 - 10/14/2017 President, Wisconsin Dermatological Society |
NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS: |
09/26/2008 - 09/28/2008 Chair, Immunology Workshop ITSCC Meeting, Essex |
2011 - 2014 Board Member, Board, International Transplant Skin Cancer Collaborative |
2011 - 2015 Member, Education and Volunteers Abroad Committee, American Academy of Dermatology |
2011 - 2014 Member, Cutting Edge Research Committee, American Society of Dermatologic Surgery |
08/01/2013 - Present Member, Cutaneous Oncology Workgroup, American Academy of Dermatology |
2017 - 2021 Melanoma/Skin Cancer Community Programs Committee, American Academy of Dermatology |
10/01/2021 - Present Co-Chair, Research Committee, Association of American Cosmetic Dermatologist |
2023 - Present Collaborate Research Task Force member, American Society of Laser Medicine and Surgery |
2023 - Present Member, Hungarian American Section Leadership Committee, Magyar Dermatologia Tarsulat |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
Local |
Edit B. Olasz, Innovations in Facial Aesthetic Medicine: Mastering the Art and Science of Injectables, Resident CME Injection Training Workshop, Medical College of Wisconsin, 05/29/2013 |
Edit B. Olasz, Innovations in Facial Aesthetic Medicine: Mastering the Art and Science of Injectables, Resident Aesthetic CME workshop, Milwaukee, WI, 05/30/2014 |
Edit B. Olaz, Skin cancer: you can prevent it, Pewaukee Town Hall Educational Event, Pewaukee, WI, 03/16/2015 |
Edit B. Olasz, Aging gracefully, Women's Health Conference, Brookfield, WI, 04/24/2015 - 04/24/2014 |
Olasz EB, Caring for your skin, Wellness Event Cancer Center Froedtert Hospital, Milwaukee, WI, 03/14/2016 |
Olasz EB, Decoding Skin Care Products, Open House FORME, Milwaukee, WI, 10/2017 |
Olasz Harken, Fundamentals of Laser Surgery, MCW Plastic Surgery Department Residency Lectures, Milwaukee, 02/2020 - Present |
Olasz Harken EB, Cosmeceuticals, Lecture for ENT residents MCW, Milwaukee, MCW, 05/24/2021 - 2021 |
Olasz Harken EB, Injection Workshop for Plastic Surgery Residents, Plastic Surgery teaching workshop, Department of Plastic Surgery, MCW, 01/24/2022 |
Olasz Harken EB, Laser fundamentals, MCW ENT Resident Lecture, Milwaukee, WI, 01/24/2022 |
Olasz Harken EB, Cadaver Workshop, Cosmetic Workshop, Milwaukee, WI, 04/29/2022 |
Olasz Harken EB, Injectables Workshop, MCW Plastic Surgery Resident Workshop Leader, Milwaukee, WI, 02/20/2023 |
Regional |
Edit B. Olasz, Photoprotection and Vitamin D, Wisconsin Society of School Nurses, Milwaukee, WI, 10/06/2011 |
Edit B. Olasz, SCC invasion - how to help transplant patients to fight the battle, Wisconsin Dermatological Society Fall Meeting, Milwaukee, WI, 11/03/2012 |
Edit B. Olasz, SCC invasion - how to help our transplant patients to fight the battle, Meeting of the Colorado Dermatological Society, Denver, CO, 02/03/2014 |
Olasz EB, Photodynamic Therapy for Benign Neurofibromas, Regional Neurofibroma Patient Support Meeting, Milwaukee, WI, 04/16/2016 |
Olasz Harken EB, Cosmeceuticals, Grand Rounds UVA Department of Dermatology, Richmond, VA, Virtual, 10/26/2022 |
National |
Edit B. Olasz, W. Phillip Werschler, Evaluating the cosmetic patient, American Society for Dermatologic Surgery, Washington DD, 10/23/2010 |
Edit B. Olasz, Infections in Immunosuppressed patients, Annual Meeting of the American Academy of Dermatology, New Orleans, LA, 02/2011 |
W. Philip Werschler, Edit B Olasz, S. Manjula Jegasothy, Hema Sundaram,, Live Patient Workshop on Neurotoxins/Fillers, American Society of Cosmetic Dermatology and Aesthetic Surgery, Las Vegas, NV, 12/02/2011 |
Edit B. Olasz, Combination therapy with dermal fillers, American Society of Cosmetic Dermatology and Aesthetic Surgery, Las Vegas, 12/03/2011 |
Injection Workshop, Vegas Cosmetic Surgery Meeting, Las Vegas, NV, 12/2016 |
Olasz Harken, Fillers: Rheology, adverse events, 3D structural rejuvenation, Residency training for UVC residents, Online, 07/2020 |
Patel A, Olasz Haken EB, 360 technique of treating spider angiomas with PDL, ASDS Virtual Presentation, Chicago, 10/2021 |
Konicke K, Olasz Harken EB, Nodules after injecting semipermanent fillers, Cosmetic Surgery Forum, Nashville, TN, 12/2021 |
Olasz Harken, EB, Gobble, gobble: Neck rejuvenation with combined techniques, Cosmetic Surgery Forum, Nashville, TN, 12/2021 |
Olasz Harken, EB, Regulatory update on sunscreens, Cosmetic Surgery Forum, Nashville, TN, 12/2021 |
Sabrina Popatia MD MPH, Edit Olasz Harken MD PhD, Karolyn A. Wanat MD, Kara Young MD, Callisia Clarke, MD, Stuart Wong, MD, Amy Harker-Murray MD, Monica Shukla MD, Musaddiq Awan MD, Julia Kasprzak MD, Unique clinical and histopathologic presentations of Merkel Cell Carcinoma (MCC) in renal transplant recipients, International Transplant Skin Cancer Collaborative Biannual Meeting, Essex, MA, 10/23/2022 |
International |
Edit B. Olasz, Marcy Neuburg, Stuart Wong, Chemoprevention of skin cancer with capecitabine in solid organ transplant patients, Annual Meeting of SCOPE, Venice, Italy, 04/10/2008 |
Edit B. Olasz, Eruptive keratoacanthoma, tumor board case., Annual Meeting of ITSCC, San Diego, CA, 03/16/2012 |
Edit B. Olasz, Metastatic SCC, tumor board case., Annual Meeting of ITSCC, Miami, FL, 03/01/2013 |
Edit B. Olasz, Transplant Dermatology, Szegedi Borgyogyaszati Napok, Szeged, Hungary, 06/26/2014 |
Edit B. Olasz, Management of field disease, the use of chemowraps and beyond, American Academy of Dermatology Annual Meeting, San Francisco, 03/20/2015 |
Edit B. Olasz, Volunteerism Abroad, American Academy of Dermatology Annual Meeting, San Francisco, CA, 03/20/2015 |
Olasz EB et al, Management of Field Disease;
The Use of Chemowraps and Beyond, AAD, San Francisco, CA, 03/2015 |
Edit B. Olasz, Field treatment for actinic keratosis, Europen Academy of Dermatovenerology, Coppenhagen, Denmark, 10/07/2015 |
Olasz EB, Know your pharmacist, Volunteerism Abroad Focus Session, AAD, Washington DC, 03/05/2016 |
Michalski B, Olasz EB et al, Development of Metastatic Xenograft Model of Cutaneous Squamous Cell Carcinoma, SID Annual Meeting, Scottsdale, AZ, 05/2016 |
Olasz EB, Freeze it, heat it, melt it away! A review of non-surgical fat reduction for the dermatologist, Hungarian Dermatological Society Cosmetic Meeting, Pecs, Hungary, 06/03/2016 |
Edit B. Olasz, Microneedle, the tool that delivers, Hungarian German Cosmetic Dermatology Meeting, Pecs, Hungary, 06/04/2016 |
Olasz EB et al, Development of Metastatic Xenograft Model of Cutaneous Squamous Cell Carcinoma, ITSCC Meeting, Boston MA, 09/2016 |
Olasz EB et al, How to treat SCC in patients with imunosuppression or hematologic diseases, EADV, Vienna, Austria, 10/01/2016 |
Olasz EB, Know your pharmacist, AAD Annual Meeting, Orlando FL, 03/04/2017 |
Olasz EB et al, Development of Metastatic Xenograft Model of Cutaneous Squamous Cell Carcinoma, SCOPE Annual Meeting, Prague, Check Republic, 03/26/2017 |
Edit B. Olasz Harken, Management of vascular occlusion by non-hyaluronic acid fillers, Cosmetic Surgery Forum, Las Vegas, Nevada, 11/30/2017 - 12/02/2017 |
Olasz EB, Duncan N, Kasprzak J, Bender N, Transformation of eruptive keratoacanthomas following intralesional chemotherapy into metastatic squamous cell carcinoma in a renal transplant patient, SCOPE Meeting, Zurich, Switzerland, 04/19/2018 - 04/22/2018 |
Olasz EB, Management of Squamous Cell Carcinoma in Solid Organ Transplant Patients, European Academy of Dermatovenerology, Budva, Montenegro, 05/03/2018 - 05/05/2018 |
Olasz Harken, E, Banned, update of sunscreens, SCOPE Annual Meeting, Barcelona, Spain, 09/2019 |
Olasz Harken, Treatment of SCCis with microneedle-assisted 5-fluorouracyl, SCOPE Annual Meeting, Barcelona, Spain, 09/2019 |
Olasz Harken, Environmental Effects of Sunscreens, Yacht Racing Forum, Bilbao, Spain, 11/27/2019 |
Olasz Harken, Sunscreens for Sailors, Mauri Pro Virtual Boat Show, Online, 10/11/2020 |
Olasz Harken, Sunscreen for Sailors, US Sailing Starboard portal, Online, 10/2020 |
Olasz Harken E, Lions and tigers and bear; Update on sunscreens, SCOPE Annual Meeting, Bochum, Germany, 11/13/2021 |
Popatia S, Olasz Harken E, Wanat K, Kasprzak, Combined Merkel cell carcinoma and SCC in an organ-transplant patient, SCOPE, Germany, 11/13/2021 |
Olasz Harken EB, Update on sunscreens, Grand Rounds, Dept Derm Univ Szeged, Szeged, Hungary, 11/17/2021 |
Olasz Harken EB, Save our Sailors, Save our Skin, Save our Seas, International Optimist Dinghy Association, Webinar International Recorded, 05/27/2022 |
Olasz Harken EB, The Business of Skincare, section chair, Innovation Academy of the American Academy of Dermatology, Vancouver, Canada, 07/23/2022 |
Olasz Harken EB, Surgical Workshop, International Society for Dermatologic Surgery, Thessaloniki, Greece, 09/22/2022 |
Olasz Harken, EB, Advanced Neurotoxin Injections of the Lower Face, Cosmetic Surgery Forum, Nashville, TN, 12/02/2022 |
Olasz Harken EB, Top 10 Cosmeceuticals, Cosmetic Surgery Forum, Nashville, TN, 12/03/2022 |
Olasz Harken, EB, Master Injection Workshop, Cosmetic Surgery Forum, Nashville, TN, 12/04/2022 |
PEER REVIEWED WORKSHOPS/PRESENTATIONS: |
Regional |
Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI: Labeling mouse bone marrow-derived dendritic cells with a positron emitting isotope F-18 for in vivo detection by high resolution PET projection imaging. SID Meeting, Chicago, IL, 2000 |
National |
Olasz EB, Roh JY, Yancey KB: A transgenic (Tg) animal model of the human autoimmune blistering disease, bullous pemphigoid (BP). Keystone Symposia, Snowbird, UT, 01/2003 - Present |
Olasz EB, Roh JY, Yee C, Vogel J, Arita K, Akiyama M, Shimizu H, Yancey KB: Human bullous pemphigoid antigen 2 (hBPAG2) in transgenic (Tg) murine skin elicits immune responses in wild type (wt) mice that show fidelity to those seen in patients with bullous pemphigo, Miami, FL, 05/2003 - Present |
Olasz EB, Lin MS, Lazarova Z, Yancey KB: Pathogenic antigen-specific immune responses to human bullous pemphigoid antigen 2 (hBPAG2) transgenic (Tg) skin in wild type (wt) mice are dependent on CD4+ T cells and are mediated by hBP, Miami, FL, 05/2003 - Present |
Lanschuetzer C, Olasz EB, Yancey KB: CD40/40L blockade prevents experimental immune responses to human bullous pemphigoid antigen 2 in epidermal basement membrane in vivo. SID Meeting, Providence, RI, 05/2004 - Present |
Hacker-Foegen MK, Salato VK, Olasz EB, Fairley JA, Lazarova Z, Lin M: Analysis of autoimmune T cell repertoire in an active pemphigus vulgaris animal model. SID Meeting, Providence, RI, 05/2004 - Present |
Olasz EB, Lanschuetzer C, Yancey KB: Development of Rag2-/-/hBPAG2 transgenic (Tg) mice for the study of in vivo unbiased immune responses to human bullous pemphigoid antigen 2 (hBPAG2) in skin. SID Meeting, Providence, RI, 05/2004 - Present |
Lazarova Z, EB Olasz, M Lin, KB Yancey: A novel murine model of ocular cicatricial pemphigoid (OCP) mediated by anti-laminin 5 IgG. SID Meeting, Providence, RI, 05/2004 - Present |
Lanschuetzer C, Olasz EB, Lazarova Z, Yancey KB: Transient anti-CD40 ligand costimulatory blockade induce CD4 cells that mediate antigen-specific unresponsiveness. SID Meeting, St. Louis, 05/2005 - Present |
Di Zenzo G, Calabresi V, Olasz EB, Yancey KB, Zambruno G: Intramolecular epitope-spreading against BPAG2 during the humoral response of mice grafted with BPAG2 (hBPAG2) transgenic skin. SID Meeting, St. Louis, 05/2005 - Present |
Truitt RL, Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE: CD200-CD200R pathway and modulation of immune reaction in the skin. SID Meeting, St. Louis, 05/2005 - Present |
Holmes W, Olasz EB, Drolet BA: Congenital and infantile leukemia cutis. Poster presentation, Society for Pediatric Dermatology 33rd Annual Meeting, 07/12/2007 - 07/15/2007 |
Olasz EB, Bresnahan B, Wong S, Neuburg M: Low-dose capecitabine for chemovrevention of non-melanoma skin cancer in solid organ transplant patients - update. ITSCC Meeting Essex, 09/26/2008 - 09/28/2008 |
N Hoffman, EB Olasz, Chemowrap treatment of actinic damage in solid-organ transplant patients, Annual Meeting of the American Society for Dermatologic Surgery, Atlanta, GA, 10/12/2012 |
M Junck, F. Wilson, EB Olasz, Eruptive keratoacanthomas after radiation treatment, Annual Meeting of the Society for Investigative Dermatology, Chicago, IL, 10/03/2013 |
Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI: Labeling mouse bone marrow-derived dendritic cells with a positron emitting isotope F-18 for in vivo detection by high resolution PET projection imaging. Keystone Symposia, Taos, NM, 2001 |
Olasz EB, Katz SI: Mouse bone marrow-derived cells do not effectively cross-present haptens and soluble proteins on MHC class II molecules. SID Meeting, Washington DC, 2001 |
Olasz EB: A transgenic (Tg) animal model for bullous pemphigoid (BP). Resident/Fellow Forum, AAD Annual Meeting, Washinton DC, 2004 |
International |
Olasz E: Effect of IL-8 on the immune-associated cell surface markers of human keratinocytes. European Students' Conference of the Charite. Berlin, Germany, 10/21/1993 - 10/23/1993 |
Olasz E, Kemeny L, Michel G, Dobozy A, Ruzicka T: Effect of IL-8 on the cell surface markers of human keratinocytes. Proceedings of the Annual Meeting of the Hungarian Society for Immunology. Lillafured, Hungary, 10/28/1993 - 10/30/1993 |
Olasz E: Pustular psoriasis in childhood. Proceedings of the Hungarian Dermatological Society. Budapest, Hungary, 12/17/1995 - 12/18/1995 |
Olasz E: Detection of interleukin-10 receptor on human keratinocytes. Proceedings of the Annual Meeting of the Young Hungarian Dermatologists. Kecskemet, Hungary, 04/19/1996 - 04/21/1996 |
Olasz E: Gorlin-Goltz syndrome. Proceedings of the I. Congress of German-Hungarian Dermatological Societies, Szeged, Hungary, 05/17/1996 - 05/19/1996 |
Olasz E, Kemeny L, Mirmohammadsadegh A, Jarzebska-Duessen B, Muschen A, Michel G, Ruzicka T, Dobozy A.: Detection of interleukin-10 receptor on human epidermal cells. ESDR Annual Meeting, Amsterdam, Netherlands, 09/28/1996 - Present |
Olasz E.: Sweet syndrome. Proceedings of the Annual Meeting of the Hungarian Dermatological Society, Budapest, Hungary, 12/13/1996 - 12/14/1996 |
Olasz EB, Bresnahan B, Wong S, Neuburg M: Low-dose capecitabine for chemoprevention of non-melanoma skin cancer in solid organ transplant patients. SCOPE Meeting Venice, Italy, 04/11/2008 - 04/13/2008 |
Rosenblum MD, Woodliff JE, Olasz EB, Yancey KB, Truitt RL: CD200-CD200R signaling in cutaneous immune homeostasis. International Investigative Dermatology Meeting • Kyoto, 05/14/2008 - 05/18/2008 |
Rafiee R, Van den Berg F, Janson M, Olasz EB, Baker J, Fish B, Nelson V, Wellner M, Moulder J, Lazarova Z: Effect of curcumin on the epidermal basement membrane proteins following chronic radiation injury. International Investigative Dermatology Meeting. Kyoto, 05/14/2008 - 05/18/2008 |
M DeMara, N Duncan, M Neuburg, S Wong, Z. Lazarova, Edit B. Olasz, Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma, Annual Meeting of the Society for Investigative Dermatology, Atlanta, GA, 05/05/2010 - 05/08/2010 |
Edit B. Olasz, Olasz (4) Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma., SCOPE Annual Meeting, Dundee, Scotland, 06/16/2011 - 06/18/2011 |
Olasz EB, Michalski B, Schock A, Duncan N, Lopez A, Neuburg M, Flister M, Lazarova Z, Development of metastatic xenograft model of cutanesous squamous cell carcinoma, Society for Investigative Dermatology, Scottsdale, AZ, 05/12/2016 - Present |
Olasz Harken, Lower face injections with neuromodulators, Cosmetic Surgery Forum, Nashville TN, 12/2019 |
COMMITTEE SERVICE: |
Medical College of Wisconsin |
2018 - Present Member, FORME Aesthetic and Vein Leadership Committee, Medical College of Wisconsin |
MEDICAL COLLEGE TEACHING ACTIVITIES: |
Medical Student Education |
09/2009 - Present Skin unit small group teaching |
Resident and Fellow Education |
07/29/2022 4 hour cosmetic workshop |
09/30/2022 4 hour cosmetic workshop |
EXTRAMURAL TEACHING: |
Resident and Fellow Education |
09/01/2008 - Present Medical College of Wisconsin, Department of Dermatology, Surgical and procedural dermatology lectures as part of surgical curriculum |
09/01/2008 - Present MCW Dermatology, Pig's feet practical surgery workshops |
09/01/2008 - Present MCW Dermatology, Half-day cosmetic procedural workshops |
MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Medical Students |
Wallace A. Smith, Medical College of Wisconsin, 06/01/2009 - 05/01/2009 Summer Researh and Research Track Mentor |
Timothy Chang, Medical College of Wisconsin, 06/01/2009 - 05/01/2012 Summer Researh and Research Track Mentor |
Madeline Pokorny, Medical College of Wisconsin, 06/01/2010 - 05/01/2012 Clinical Track Mentor |
Nicholas Zajdel, MCW, 2013 - 2014 Review paper mentor |
Kathryn Konicke, Medical College of Wisconsin, 03/01/2015 - Present Pathway mentor |
Graduate Students |
MPh Students Advised |
Megan DeMara, Medical College of Wisconsin, 10/01/2008 - 06/30/2010 Skin Cancer Risk Perception in Solid Organ Transplant Patients |
Danessa Sandmann, Medical College of Wisconsin, 08/01/2013 - Present Capsone Project |
Residents |
Dan Mosel, MCW, 2010 - 2011 Clinical research project mentor |
Kathryn Konicke, Medical College of Wisconsin, 07/01/2017 - Present Manuscript, Presentation, Manuscript, Presentation |
Ashaki Patel, Medical College of Wisconsin, 07/01/2020 - Present presentation, Presentation at ASDS |
Justin Fazio, Medical College of Wisconsin, 07/2020 - 09/2021 Book Chapter, Book Chapter of BCC in Transplant Patient |
Sabrina Popatia, Medical College of Wisconsin, 09/01/2021 - Present Presentation, Presentation at SCOPE Germany |
Sabrina Popatia, Medical College of Wisconsin, 2021 - Present Oral presentation, Paper, Oral presentation at International meeting, article submission |
Faculty |
Julia Kasprzak, Medical College of Wisconsin, 07/01/2018 - Present Research Projects and patient care, Casper SCC project, Transplant clinics |
EXTRAMURAL STUDENTS, FACULTY, RESIDENTS, AND CLINICAL/RESEARCH FELLOWS MENTORED: |
Residents |
Elizabeth Havey, MCW Dermatology, 2009 Presentation mentor |
Katharina Bassett, MCW Dermatology, 2010 Presentation mentor |
Stephen Humphrey and Michelle Bayer, MCW Dermatology, 2011 - Present Belize Teledermatology project mentor |
Nicole Huffmann, MCW Dermatology, 2012 ASDS abstract mentor |
Alex Maley MD, Aurora Transitional Residency Program, 2013 - 2014 Review paper mentor |
Marianna Junck, MCW Dermatology, 2013 ASDS abstract mentor |
Ashley Sullivan, MCW Dermatology, 2014 ASDS abstract mentor |
PROGRAMMATIC DEVELOPMENTS: |
Clinical Programs |
07/01/2008 - Present Specialty Clinic for High-Risk Transplant Patients, Department of Dermatology, Medical College of Wisconsin |
07/01/2008 - Present Cosmetic and Laser Clinic, Department of Dermatology, Medical College of Wisconsin |
07/01/2011 - Present VA Teledermatology Service |
COMMUNITY SERVICE ACTIVITIES: |
05/23/2011 - 05/27/2011 Mobile Medical Mission, Dermatology Volunteer Service in Kingstown, St. Vincent, Grenadines |
05/28/2012 - 06/01/2012 Mobile Medical Mission, Dermatology Volunteer Service in Kingstown, St. Vincent, Grenadines |
05/27/2013 - 05/31/2013 Mobile Medical Mission, Dermatology Volunteer Service in Kingstown, St. Vincent, Grenadines |
10/21/2013 - 10/25/2013 Health Volunteers Overseas, Teaching Dermatology at the Department of Dermatology, Hue, Vietnam |
05/2015 - 05/2019 Ann's Hope Melanoma Run Skin Cancer Screening |
02/18/2018 Community education lecture about skin cancer and sun protection at the Miami Boat Show, Miami, FL |
05/20/2018 SPOT ME skin cancer screening at the Annual Ann's Hope Melanoma Run, Milwaukee Wisconsin |
08/2018 Pewaukee Yacht Club, Pewaukee WI Skin Cancer Education |
06/20/2019 Queen's Cup Milwaukee South Shore Yacht Club: Update on Sunscreens |
07/20/2020 - Present San Francisco Yacht Club Wednesday lunch series: Sunscreens |
10/22/2020 - 10/22/Present Mauri Pro International Webinar: Sun protection |
06/2021 - Present Queen's Cup Milwaukee: Update on Sunscreens |
07/29/2021 - Present Starboard Portal Webinar: Sunscreens |
10/2021 - Present US Sailing Team Webinar: Skin care for sailors |
05/27/2022 - Present International Opti Dinghy Association Webinar: Sun Protection for sailors |
2023 - Present US Sailing Donor and Skin Care advisor |
GLOBAL HEALTH ACTIVITIES: |
2008 - 2011 Volunteer Dermatologist St Vincent, The Grenadines |
10/2013 - Present Teaching dermatology for dermatologist in Hue, Vietnam |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. Daniel R. Knabel, Edit B. Olasz Chemoprevention of non-melanoma skin cancer The Dermatologist. Vol 22, Issue 12 |
2. Lindsay DP, Kharofa J, Junck M, Olasz E, Frank Wilson J. Eruptive keratoacanthomas after radiation therapy for keratoacanthoma centrifugum marginatum. Pract Radiat Oncol. 2015;5(3):203-206. |
3. Alexander Maley, Edit B. Olasz Skin diesease in solid organ transplant recipients The Dermatologist. Vol 22, Issue 2, February 2014 |
4. Bouwes Bavinck JN, Harwood CA, Genders RE, Wisgerhof HC, Plasmeijer EI, Mitchell L, Olasz EB, Mosel DD, Pokorney MS, Serra AL, Feldmeyer L, Baumann Conzett K, Piaserico S, Belloni Fortina A, Jahn K, Geusau A, Gerritsen MJ, Seckin D, Gulec AT, Cetkovska P, Ricar J, Imko-Walczuk B, Proby CM, Hofbauer GF. Pain identifies squamous cell carcinoma in organ transplant recipients: the SCOPE-ITSCC PAIN study. Am J Transplant. 2014 Mar;14(3):668-76. |
5. Randhawa J, Wong S, Atallah E, Olasz E. Clinical regression of squamous cell carcinoma and keratoacanthomas in a patient treated with a hypomethylating agent. Int J Dermatol. 2014 Jan;53(1):e13-4. |
6. Dziunycz PJ, Lazarova Z, Duncan N, Wong S, Neuburg M, Hofbauer GF, Olasz EB. EGFRvIII expression in squamous cell carcinoma of the skin. JAMA Dermatol. 2013 Oct;149(10):1240-2. |
7. Colegio OR, Hanlon A, Olasz EB, Carucci JA. Sirolimus reduces cutaneous squamous cell carcinomas in transplantation recipients. J Clin Oncol. 2013 Sep 10;31(26):3297-8. |
8. Mosel D, Harris L, Fisher E, Olasz E, Wilson B. Disseminated Nocardia infection presenting as hemorrhagic pustules and ecthyma in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome. J Dermatol Case Rep. 2013 Jun 30;7(2):52-5. PMCID: PMC3710679 |
9. Doctrow SR, Lopez A, Schock AM, Duncan NE, Jourdan MM, Olasz EB, Moulder JE, Fish BL, Mäder M, Lazar J, Lazarova Z. A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin. J Invest Dermatol. 2013 Apr;133(4):1088-96. PMCID: PMC3594042 |
10. Habibi M, Olasz EB, Klemer DP. Two-dimensional dielectric imaging for dermatologic screening: a feasibility study. Skin Res Technol. 2012 Aug;18(3):324-31. |
11. Jourdan MM, Lopez A, Olasz EB, Duncan NE, Demara M, Kittipongdaja W, Fish BL, Mäder M, Schock A, Morrow NV, Semenenko VA, Baker JE, Moulder JE, Lazarova Z. Laminin 332 deposition is diminished in irradiated skin in an animal model of combined radiation and wound skin injury. Radiat Res. 2011 Nov;176(5):636-48. PMCID: PMC3227557 |
12. Di Zenzo G, Calabresi V, Olasz EB, Zambruno G, Yancey KB. Sequential intramolecular epitope spreading of humoral responses to human BPAG2 in a transgenic model. J Invest Dermatol. 2010 Apr;130(4):1040-7. |
13. Nishie W, Sawamura D, Olasz EB, Yancey KB, Shimizu H: A novel humanized neonatal autoimmune disease model. J Immunol. 2009 Sep 15;183(6):4088-93. |
14. Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB: Transient Anti-CD40L Co-stimulation Blockade Prevents Immune Responses Against Human Bullous Pemphigoid Antigen 2: Implications For Gene Therapy. J Invest Dermatol. 2008 Nov 27. |
15. Elsaie ML, Olasz EB, Jacob SE: Cytokines and Langerhans cells in allergic contact dermatitis. Review. G Ital Dermatol Venereol. 2008 Jun; 143(3):195-205. |
16. Olasz EB, Roh J, Yee CL, Arita K, Akiyama M, Shimizu H, Vogel JC, Yancey KB: Human Bullous Pemphigoid Antigen 2 Transgenic Skin Elicits Specific IgG in Wild-Type Mice. J Invest Dermatol. 2007 Dec; 127(12):2807-17. |
17. Nishie W, Sawamura D, Goto M, Ito K., Shibaki A, McMillan J.R, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H: Humanization of autoantigen. Nature Med. 2007 Mar; 13(3):378. |
18. Rosenblum, MD, Yancey, KB, Olasz E, Truitt RL: CD200, a "no danger" signal for hair follicles. J. Dermatol. Sci. 2006; 41:165-174. |
19. Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL: Expression of CD200 on epithelial cells of murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol. 2004 Nov; 123(5):880-7. |
20. Rosenblum MD, Olasz EB, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas KA, Truitt RL: Dendritic cell expression of CD200 promotes apoptosis-associated immune tolerance. Blood. 2004 Apr; 103(7):2691-8. |
21. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI: Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods. 2002; 1;260(1-2):137-48. |
22. Olasz EB, Linton J, Katz SI: Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. Int Immunol. 2002; 14(5):493-502. |
23. Saeki H, Wu MT, Olasz E, Hwang ST: A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo. Eur J Immunol. 2000; 30(10): 2808-14. |
24. Michel G, Mirmohammadsadegh A, Olasz E, Jarzebska-Deussen B, Muschen A, Kemeny L, Abts HF, Ruzicka T: Demonstration and functional analysis of IL-10 receptors in human epidermal cells: Decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glococorticosteroid in normal cultured keratinocyte. J Immunol. 1997 Dec; 159: (12) 6291-6297. |
25. Koszo F, Morvay M, Olasz E, Bonis B: Change of erythrocyte uroporphyrinogen decarboxylase activity during therapy in porphyria cutanea tarda. Borgyogyaszati es Venerologiai Szemle. 1996; 72:199-202. |
26. Kemeny L, Olasz E, Kenderessy SzA, Michel G, Ruzicka T, Dobozy A: Interleukin-8 induces HLA-DR expression on human keratinocytes. Int. Arch. Allergy Immunology. 1995; 106:351-356. |
27. Kemeny L, Kenderessy SzA, Olasz E, Michel G, Ruzicka T, Farkas B, Dobozy A: The interleukin-8 receptor: a potential target for antipsoriatic therapy? Eur. J. Pharmacol. 1994; 258:269-272. |
28. Kemeny L, Kenderessy SzA, Olasz E, Michel G, Ruzicka T, Dobozy A: The interleukin-8 receptor: potential target for antipsoriatic therapy. Chron. Dermatol. Vol IV-1994 N.4. |
29. Kemeny L, Olasz E, Kenderessy SzA, Michel G, Beetz A, Ruzicka T, Dobozy A: Detection and function of interleukin-8-receptor on human keratinocytes. Chron. Dermatol. 1994; 4:591-603. |
30. Olasz EB, Seline LN, Schock AM, Duncan NE, Lopez A, Lazar J, Flister MJ, Lu Y, Liu P, Sokumbi O, Harwood CA, Proby CM, Neuburg M, Lazarova Z. MicroRNA-135b Regulates Leucine Zipper Tumor Suppressor 1 in Cutaneous Squamous Cell Carcinoma. PLoS One. 2015;10(5):e0125412. PMCID: PMC4418692 |
31. Nicholas Zajdel, BS, Adam Currey, MD, J. Frank Wilson, MD, Zelmira Lazarova, MD, and Edit B. Olasz, MD, PhD Radiation Therapy for NMSC in Immunosuppressed Patients The Dermatologist. |
32. Konicke K, Olasz E. Successful Treatment of Recalcitrant Plantar Warts With Bleomycin and Microneedling. Dermatol Surg. 2016 Aug;42(8):1007-8. |
33. Bobbs M, Bayer M, Frazer T, Humphrey S, Wilson B, Olasz E, Holland K, Kuzminski J. Building a global teledermatology collaboration. Int J Dermatol. 2016 Apr;55(4):446-9. |
34. Konicke K, Knabel M, Olasz E. Microneedling in Dermatology: A Review. Plast Surg Nurs. 2017;37(3):112-115. |
35. Zajdel NJ, Smith WA, Taintor AR, Jacob SE, Olasz EB. Chemical Tattoo Treatment Leading to Systemic Cobalt Hypersensitivity. Skinmed. 2017;15(3):221-222. |
36. Olasz EB, Babakoohi S, Lazarova Z. Keratinocyte Cancer Therapies Enter the Era of Targeted and Immunotherapy: Join the Club. JAMA Dermatol. 2017 Apr 01;153(4):253-255. |
37. Jha P, Swanson K, Stromich J, Michalski BM, Olasz E. A Rare Case of Vancomycin-Induced Linear Immunoglobulin A Bullous Dermatosis. Case Rep Dermatol Med. 2017;2017:7318305. PMCID: PMC5259662 |
38. Garrett GL, Blanc PD, Boscardin J, Lloyd AA, Ahmed RL, Anthony T, Bibee K, Breithaupt A, Cannon J, Chen A, Cheng JY, Chiesa-Fuxench Z, Colegio OR, Curiel-Lewandrowski C, Del Guzzo CA, Disse M, Dowd M, Eilers R Jr, Ortiz AE, Morris C, Golden SK, Graves MS, Griffin JR, Hopkins RS, Huang CC, Bae GH, Jambusaria A, Jennings TA, Jiang SI, Karia PS, Khetarpal S, Kim C, Klintmalm G, Konicke K, Koyfman SA, Lam C, Lee P, Leitenberger JJ, Loh T, Lowenstein S, Madankumar R, Moreau JF, Nijhawan RI, Ochoa S, Olasz EB, Otchere E, Otley C, Oulton J, Patel PH, Patel VA, Prabhu AV, Pugliano-Mauro M, Schmults CD, Schram S, Shih AF, Shin T, Soon S, Soriano T, Srivastava D, Stein JA, Sternhell-Blackwell K, Taylor S, Vidimos A, Wu P, Zajdel N, Zelac D, Arron ST. Incidence of and Risk Factors for Skin Cancer in Organ Transplant Recipients in the United States. JAMA Dermatol. 2017 Mar 01;153(3):296-303. |
39. Oh CC, Hofbauer GFL, Serra AL, Harwood CA, Mitchell L, Proby CM, Olasz EB, Mosel DD, Piaserico S, Fortina AB, Geusau A, Jahn-Bassler K, Gerritsen MJP, Seçkin D, Güleç AT, Cetkovská P, Ricar J, Imko-Walczuk B, Dębska-Ślizień A, Bouwes Bavinck JN. Painful skin lesions and squamous cell carcinoma predict overall mortality risk in organ transplant recipients: a cohort study. Br J Dermatol. 2017 May;176(5):1179-1186. |
40. Olasz EB, Kis E. Electrochemotherapy - yet another innovative application. Br J Dermatol. 2016 Dec;175(6):1148-1149. |
41. Michalski B, Olasz E. What You Didn't Know About the Sun: Infrared Radiation and Its Role in Photoaging. Plast Surg Nurs. 2016;36(4):170-172. |
42. Konicke K, López-Luna A, Muñoz-Carrillo JL, Servín-González LS, Flores-de la Torre A, Olasz E, Lazarova Z. The microRNA landscape of cutaneous squamous cell carcinoma. Drug Discov Today. 2018 Apr;23(4):864-870. |
43. Mazmudar RS, Fazio J, Garland K, Tripathi R, Clark M, Olasz E, Bordeaux JS, Scott JF. Predictors of patient-initiated communication after Mohs micrographic surgery: A multi-institutional prospective cohort study. J Am Acad Dermatol. 2021 Nov;85(5):1290-1293. |
44. Michalski B, Olasz E. What You Didn't Know About the Sun: Infrared Radiation and Its Role in Photoaging. Plast Surg Nurs. 2020;40(3):166-168. |
45. Berliner JG, Schulman JM, Lazarova Z, Olasz E, Arron ST. Response of Cutaneous Squamous Cell Carcinoma to Treatment With Cetuximab. Dermatol Surg. 2019 Feb;45(2):313-316. |
46. Quirk B, Olasz E, Kumar S, Basel D, Whelan H. Photodynamic Therapy for Benign Cutaneous Neurofibromas Using Aminolevulinic Acid Topical Application and 633 nm Red Light Illumination. Photobiomodul Photomed Laser Surg. 2021 Jun;39(6):411-417. PMCID: PMC8219184 |
47. Garrett GL, Yuan JT, Shin TM, Arron ST, Transplant Skin Cancer Network (TSCN). Validity of skin cancer malignancy reporting to the Organ Procurement Transplant Network: A cohort study. J Am Acad Dermatol. 2018 Feb;78(2):264-269. |
48. Currey AD, Olasz EB, Wilson JF, Lazarova Z. Radiation therapy for non-melanoma skin cancer in immunosuppressed patients and cutaneous toxicity from this therapy Skin Diseases in the Immunocompromised. 1 May 2014:171-182. |
49. Mosel D, Harris L, Fisher E, Olasz E, Wilson B. Disseminated Nocardia infection presenting as hemorrhagic pustules and ecthyma in a woman with systemic lupus erythematosus and antiphospholipid antibody syndrome Journal of Dermatological Case Reports. 2013;7(2):52-55. |
50. Doctrow SR, Lopez A, Schock AM, Duncan NE, Jourdan MM, Olasz EB, Moulder JE, Fish BL, Mäder M, Lazar J, Lazarova Z. Erratum: A synthetic superoxide dismutase/catalase mimetic EUK-207 mitigates radiation dermatitis and promotes wound healing in irradiated rat skin (Journal of Investigative Dermatology (2013) 133 (1088-1096) DOI: 10.1038/jid.2012.410) Journal of Investigative Dermatology. June 2013;133(6):1691. |
51. Elsaie ML, Olasz E, Jacob SE. Cytokines and Langerhans cells in allergic contact dermatitis Giornale Italiano di Dermatologia e Venereologia. June 2008;143(3):195-205. |
52. Kuemmet T, Konicke K, Harken EO. Successful Treatment of Symptomatic Fibrofatty Tissue of an Involuted Infantile Hemangioma on the Cheek With Intralesional Deoxycholic Acid and Pulsed Dye Laser. Dermatol Surg. 2022 Apr 01;48(4):476-477. |
53. Massey PR, Schmults CD, Li SJ, Arron ST, Asgari MM, Bouwes Bavinck JN, Billingsley E, Blalock TW, Blasdale K, Carroll BT, Carucci JA, Chong AH, Christensen SR, Chung CL, DeSimone JA, Ducroux E, Escutia-Muñoz B, Ferrándiz-Pulido C, Fox MC, Genders RE, Geusau A, Gjersvik P, Hanlon AM, Olasz Harken EB, Hofbauer GFL, Hopkins RS, Leitenberger JJ, Loss MJ, Del Marmol V, Mascaró JM Jr, Myers SA, Nguyen BT, Oliveira WRP, Otley CC, Proby CM, Rácz E, Ruiz-Salas V, Samie FH, Seçkin D, Shah SN, Shin TM, Shumack SP, Soon SL, Stasko T, Zavattaro E, Zeitouni NC, Zwald FO, Harwood CA, Jambusaria-Pahlajani A. Consensus-Based Recommendations on the Prevention of Squamous Cell Carcinoma in Solid Organ Transplant Recipients: A Delphi Consensus Statement. JAMA Dermatol. 2021 Oct 01;157(10):1219-1226. PMCID: PMC9937447 |
54. Siller A, Blaszak SC, Lazar M, Olasz Harken E. Update About the Effects of the Sunscreen Ingredients Oxybenzone and Octinoxate on Humans and the Environment. Plast Surg Nurs. 2019;39(4):157-160. |
55. Siller A, Blaszak SC, Lazar M, Olasz Harken E. Update About the Effects of the Sunscreen Ingredients Oxybenzone and Octinoxate on Humans and the Environment. Plast Surg Nurs. 2018;38(4):158-161. |
56. Nicholas Zajdel, BS, Adam Currey, MD, J. Frank Wilson, MD, Zelmira Lazarova, MD, and Edit B. Olasz, MD, PhD. Radiation Therapy for NMSC in Immunosuppressed Patients The Dermatologist. . |
57. Daniel R. Knabel, Edit B. Olasz. Chemoprevention of non-melanoma skin cancer The Dermatologist. Vol 22, Issue 12, December 2014. |
58. Alexander Maley, Edit B. Olasz. Skin diesease in solid organ transplant recipients The Dermatologist. Vol 22, Issue 2, February 2014. |
59. Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies. J Immunol. 2009 Sep 15;183(6):4088-93. |
60. Lanschuetzer CM, Olasz EB, Lazarova Z, Yancey KB. Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy. J Invest Dermatol. 2009 May;129(5):1203-7. PMCID: PMC2681490 |
61. Elsaie ML, Olasz E, Jacob SE. Cytokines and Langerhans cells in allergic contact dermatitis. G Ital Dermatol Venereol. 2008 Jun;143(3):195-205. |
62. Olasz EB, Yancey KB. Bullous pemphigoid and related subepidermal autoimmune blistering diseases. Curr Dir Autoimmun. 2008;10:141-66. |
63. Olasz EB, Roh J, Yee CL, Arita K, Akiyama M, Shimizu H, Vogel JC, Yancey KB. Human bullous pemphigoid antigen 2 transgenic skin elicits specific IgG in wild-type mice. J Invest Dermatol. 2007 Dec;127(12):2807-17. PMCID: PMC2546607 |
64. Nishie W, Sawamura D, Goto M, Ito K, Shibaki A, McMillan JR, Sakai K, Nakamura H, Olasz E, Yancey KB, Akiyama M, Shimizu H. Humanization of autoantigen. Nat Med. 2007 Mar;13(3):378-83. |
65. Rosenblum MD, Yancey KB, Olasz EB, Truitt RL. CD200, a "no danger" signal for hair follicles. J Dermatol Sci. 2006 Mar;41(3):165-74. |
66. Rosenblum MD, Olasz EB, Yancey KB, Woodliff JE, Lazarova Z, Gerber KA, Truitt RL. Expression of CD200 on epithelial cells of the murine hair follicle: a role in tissue-specific immune tolerance? J Invest Dermatol. 2004 Nov;123(5):880-7. |
67. Rosenblum MD, Olasz E, Woodliff JE, Johnson BD, Konkol MC, Gerber KA, Orentas RJ, Sandford G, Truitt RL. CD200 is a novel p53-target gene involved in apoptosis-associated immune tolerance. Blood. 2004 Apr 01;103(7):2691-8. |
68. Olasz EB, Linton J, Katz SI. Soluble proteins and haptens on bone marrow-derived dendritic cells are presented to host CD4 T cells in an MHC-restricted manner. Int Immunol. 2002 May;14(5):493-502. |
69. Olasz EB, Lang L, Seidel J, Green MV, Eckelman WC, Katz SI. Fluorine-18 labeled mouse bone marrow-derived dendritic cells can be detected in vivo by high resolution projection imaging. J Immunol Methods. 2002 Feb 01;260(1-2):137-48. |
70. Saeki H, Wu MT, Olasz E, Hwang ST. A migratory population of skin-derived dendritic cells expresses CXCR5, responds to B lymphocyte chemoattractant in vitro, and co-localizes to B cell zones in lymph nodes in vivo. Eur J Immunol. 2000 Oct;30(10):2808-14. |
71. Michel G, Mirmohammadsadegh A, Olasz E, Jarzebska-Deussen B, Müschen A, Kemény L, Abts HF, Ruzicka T. Demonstration and functional analysis of IL-10 receptors in human epidermal cells: decreased expression in psoriatic skin, down-modulation by IL-8, and up-regulation by an antipsoriatic glucocorticosteroid in normal cultured keratinocytes. J Immunol. 1997 Dec 15;159(12):6291-7. |
72. Kemény L, Kenderessy AS, Olasz E, Michel G, Ruzicka T, Farkas B, Dobozy A. The interleukin-8 receptor: a potential target for antipsoriatic therapy? Eur J Pharmacol. 1994 Jun 13;258(3):269-72. |
73. Minkis K, Bolotin D, Council ML, Bar A, Farah RS, Kibbi N, Miest RYN, Orringer JS, Ortiz A, Suozzi KC, Vashi NA, Yoo SS, Albrecht J, Blalock TW, Bruce AJ, Deng M, Desai S, Eshaq M, Fiessinger LA, Ghareeb E, Greywal T, Hebert AA, Hooper D, Hordinsky M, Hu JC, Jibbe A, Joo J, Kelly KM, Kenkare S, Khetarpal S, Kole LCS, Kourosh AS, Kuhn H, Lee KC, Lucas R, Luke J, Mafee M, Mayo TT, Nawas ZY, Olasz Harken EB, Pearlstein MV, Petronic-Rosic V, Robinson CA, Rogge MN, Saikaly SK, Schenck OL, Schlick CA, Shahabi L, Shipp DM, Shive M, Silapunt S, Stratman EJ, Sulewski R, Suggs AK, Tolaymat L, Ward KHM, Weinstein Velez M, Zeichner J, Kang BY, Ibrahim SA, Christensen RE, Anvery N, Dirr MA, Lawrence N, Alam M. Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic Dermatology. Arch Dermatol Res. 2022 Dec 3. doi: 10.1007/s00403-022-02471-8. Epub ahead of print. PMID: 36463367. |
74. Minkis K, Bolotin D, Council ML, Bar A, Farah RS, Kibbi N, Miest RYN, Orringer JS, Ortiz A, Suozzi KC, Vashi NA, Yoo SS, Albrecht J, Blalock TW, Bruce AJ, Deng M, Desai S, Eshaq M, Fiessinger LA, Ghareeb E, Greywal T, Hebert AA, Hooper D, Hordinsky M, Hu JC, Jibbe A, Joo J, Kelly KM, Kenkare S, Khetarpal S, Kole LCS, Kourosh AS, Kuhn H, Lee KC, Lucas R, Luke J, Mafee M, Mayo TT, Nawas ZY, Olasz Harken EB, Pearlstein MV, Petronic-Rosic V, Robinson CA, Rogge MN, Sachs DL, Saikaly SK, Schenck OL, Schlick CA, Shahabi L, Shipp DM, Shive M, Silapunt S, Suggs AK, Tolaymat L, Ward KHM, Weinstein Velez M, Zeichner J, Kang BY, Ibrahim SA, Christensen RE, Anvery N, Dirr MA, Lawrence N, Alam M. The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacy. Arch Dermatol Res. 2022 Dec 2. doi: 10.1007/s00403-022-02489-y. Epub ahead of print. PMID: 36456760. |
75. Minkis K, Bolotin D, Council ML, Bar A, Farah RS, Kibbi N, Miest RYN, Orringer JS, Ortiz A, Suozzi KC, Vashi NA, Yoo SS, Albrecht J, Blalock TW, Bruce AJ, Deng M, Desai S, Eshaq M, Fiessinger LA, Ghareeb E, Greywal T, Hebert AA, Hooper D, Hordinsky M, Hu JC, Jibbe A, Joo J, Kelly KM, Kenkare S, Khetarpal S, Kole LCS, Kourosh AS, Kuhn H, Lee KC, Lucas R, Luke J, Mafee M, Mayo TT, Nawas ZY, Olasz Harken EB, Pearlstein MV, Petronic-Rosic V, Robinson CA, Rogge MN, Saikaly SK, Schenck OL, Schlick CA, Shahabi L, Shipp DM, Shive M, Silapunt S, Stratman EJ, Sulewski R, Suggs AK, Tolaymat L, Ward KHM, Weinstein Velez M, Zeichner J, Kang BY, Ibrahim SA, Christensen RE, Anvery N, Dirr MA, Lawrence N, Alam M. Needs and Gaps in Resident Trainee Education, Clinical Patient Care, and Clinical Research in Cosmetic Dermatology: Position Statement of the Association of Academic Cosmetic Dermatology. Arch Dermatol Res. 2023 Aug;315(6):1755-1762. |
76. Minkis K, Bolotin D, Council ML, Bar A, Farah RS, Kibbi N, Miest RYN, Orringer JS, Ortiz A, Suozzi KC, Vashi NA, Yoo SS, Albrecht J, Blalock TW, Bruce AJ, Deng M, Desai S, Eshaq M, Fiessinger LA, Ghareeb E, Greywal T, Hebert AA, Hooper D, Hordinsky M, Hu JC, Jibbe A, Joo J, Kelly KM, Kenkare S, Khetarpal S, Kole LCS, Kourosh AS, Kuhn H, Lee KC, Lucas R, Luke J, Mafee M, Mayo TT, Nawas ZY, Olasz Harken EB, Pearlstein MV, Petronic-Rosic V, Robinson CA, Rogge MN, Sachs DL, Saikaly SK, Schenck OL, Schlick CA, Shahabi L, Shipp DM, Shive M, Silapunt S, Suggs AK, Tolaymat L, Ward KHM, Weinstein Velez M, Zeichner J, Kang BY, Ibrahim SA, Christensen RE, Anvery N, Dirr MA, Lawrence N, Alam M. The Association of Academic Cosmetic Dermatology: improving cosmetic dermatology education through collaboration, research, and advocacy. Arch Dermatol Res. 2023 Jul;315(5):1449-1452. |
Books, Chapters, and Reviews |
1. Olasz, EB, Neuburg M.: Transplant Dermatology. Sauer's Manual of Skin Diseases. Accepted, in print. |
2. Olasz, EB, Yancey, KB: Bullous pemphigoid and related autoimmune subepidermal blistering diseases, in Current Directions in Autoimmunity: Dermatologic Immunity, Nickoloff, B.J., Nestle, F.O., (Eds.), Theofilopoulos, A.N. (Series Ed.), Karger Press, Basel Curr Dir Autoimmun. 2008; 10:141-66. |
3. Skin disease in solid organ transplant recipients. A Maley, EB Olasz. The Dermatologist, Cover, Volume 22 - Issue 2 - February 2014 |
4. Adam D. Currey, Edit B. Olasz, Frank J. Wilson, Zelmira Lazarova: Skin Diseases in the Immunocompromised Patients. J Hall, Springer 2014 |
5. D. Knabel, EB. Olasz. Chemoprevention in Transplant Patient. Review. The Dermatologist. In print, 2014. |
6. Tomori et al. Atlas of Dermatologic Diseases in Solid Organ Transplant Patients
Chapter: Basal Cell Carcinoma
Fazio J, Olasz Harken EB 2022 fall ISBN: 978-3-031-13335-0 |
Editorials, Letters to Editor, Other |
1. US Patent # 20050169870,"Methods of Modulating CD200". Issue date: January 31, 2005. Patent Holder: DNAX Research Institute, Palo Alto, CA. Co-Inventors R. Truitt, M. Rosenblum and E. Olasz |
Abstracts |
1. MicroRNA-135b inhibits tumor progression by down-regulation of leucine zipper tumor suppressor 1 in cutaneous squamous cell carcinoma. EB Olasz,M Neuburg,L Seline,A Schock,N Duncan,A Lopez,J Lazar,1,MJ Flister,Y Lu,P Liu,CA Harwood,CM Proby and Z Lazarova. J Invest Dermatol 2014 134: S34 |
2. Bobbs M, Bayer M, Vann W, Frazer T, Wilson B, Olasz E, Holland K, Humphrey S, Leib S, Kuzminski K. Validating a need for a teledermatology partnership in the Toledo District of southern Belize (abstract). Ann Glob Health. 2014 May-Jun;80(3):214. |
3. MiR-29b as a potential therapeutic target of radiation-induced skin fibrosis. EB Olasz,NE Duncan,AM Schock,MC Ngongang,LN Seline,A Lopez,J Lazar,P Liu and Z Lazarova1 J Invest Dermatol 2013 133: S252 |
4. M Junck, EB Olasz. Eruptive Keratoacanthomas Following Radiation American Society for Dermatological Surgery Annual Meeting, Chicago, IL 2013 |
5. M Junck, EB Olasz. Eruptive Keratoacanthomas Following Radiation Therapy Wisconsin Dermatological Society Annual Meeting, Milwaukee, WI 2013 |
6. N Huffman, EB Olasz. Successful Treatment of Diffuse Actinic Damage on the Upper and Lower Extremities in Solid Organ Transplant Patients with 5-Fluorouracil Under Unna Wrap. Society for Dermatologic Surgery Annual Meeting,Atlanta GA, 2012 |
7. Angiogenesis gene expression profiling in irradiated skin. A Lopez, A Schock, NE Duncan, EB Olasz, W Kittipongdaja, SR Doctrow, BL Fish, JE Moulder, Z Lazarova. Radiation Research Society Annual Meeting, 2011, Poland |
8. Effect of superoxide dismutase (SOD)/catalase mimemetic EUK-207 on the radiation-induced skin injury. MM. Jourdan, A. Lopez, EB. Olasz, BL Fish, M. Mader, A. Schock, B. Althouse, SR. Doctrow, Z. Lazarova. JID(2010)Vol130:S2 |
9. Expression of epidermal growth factor receptor (EGFR) and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma M DeMara,1 N Duncan,1 S Wong,2 M Neuburg,1 Z Lazarova1 and EB Olasz1 J Invest Dermatol 131: S18 2010 |
10. K Bassett, EB Olasz Capecitabine for Chemoprevention of Non-Melanoma Skin Cancer in Organ Transplant Patients. Wisconsin Dermatological Society Annual Meeting, Milwaukee, WI 2010 |
11. Gene expression profiling in irradiated skin. A. Lopez, X. Wu, EB. Olasz, J. Lazar, R. Sells, BL. Fish, M. Mader, A. Schock, BJ. Althouse, JE. Moulder, Z. Lazarova. Radiation Research Society Annual Meeting 2010 |
12. Skin cancer risk perception in renal transplant recipients.TW. Chang, M. DeMara, B. Vasudev and EB. Olasz. JID(2010)Vol130;S68 |
13. E. Havey, EB OLasz. Squamous Cell Carcinoma (SCC) Treated with 5-Fluorouracil (5-FU) Under Weekly Unna Boot Occlusion Wisconsin Dermatologic Society Meeting 2009 |
14. Acute animal model of radiation-altered wound healing. M. Jourdan, EB. Olasz, J. Moulder, B. Fish, M. Mader, A. Schock, A. Lopez, Z. Lazarova. JID(2009)Vol129;S5 |
15. Mitigation of combined radiation and skin wound injury by SOD/catalase mimetic EUK-207. M. Jourdan, EB. Olasz, JE. Moulder, BL. Fish, M. Mader, A. Schock, N. Morrow, V. Semenenko, SR. Doctrow, Z. Lazarova RRS 2009, Savannah, USA |
16. Effect of curcumin on the epidermal basement membrane proteins following chronic radiation injury. P. Rfiee, F. Van den Bergh, M. Janson, EB. Olasz, J. Baker, B. Fish, V. Nelson, M. Wellner, J. Moulder, Z. Lazarova JID(2008)Vol128; S45 |
17. Nishie W, Sawamura D, Goto M, Shibaki A, McMillan JR, Nakamura H, Olasz EB, Yancey KB, Akiyama M, Shimizu H: Collagen XVII knockout mice and their transgenic rescue using human collagen XVII cDNA. J Invest Dermatol. 2006;126:S21. |
18. Olasz E, Yamada N, Linton J, Katz SI: Assessment of bone-marrow derived dendritic cells for protein and contact hypersensitivity. J Invest Dermatol. 1999; 112: (4) 523-523. |
19. Kemeny L, Kenderessy AS, Olasz E, Dobozy A.: Nitric oxide is involved in the antimicrobial activity of keratinocytes. J Invest Dermatol. 1997 Apr; 108: (4)625-625. |
20. Olasz E, Kemeny L, Mirmohammadsadegh, et al.: Detection of IL-10 receptor on human epidermal cells. J Invest Dermatol. 1996 Sept; 107: (3)178-178. |
21. Olasz E, Kemeny L, Mirmohammadsadegh, et al.: Detection of IL-10 receptor on human epidermal cells. J Invest Dermatol. 1996 Sept; 107: (3)178-178. |
22. Kemeny L, Olasz E, Kenderessy Sz. A, Michel G, Beetz A, Ruzicka T, Dobozy A: Inhibition of interleukin-8-induced HLA-DR expression on human keratinocytes by antipsoriatic drugs. J. Dermatol Sci. 1993; 6:69. |
23. Kemeny L, Olasz E, Kenderessy Sz. A, Michel G, Beetz A, Ruzicka T, Dobozy A: Inhibition of interleukin-8-induced HLA-DR expression on human keratinocytes by antipsoriatic drugs. J. Invest. Dermatol. 1993; 101:443. |
24. Laminin 332 expression and processing is altered in irradiated and wounded skin. A Lopez,EB Olasz,NE Duncan,A Schock,W Kittipongdaja,BL Fish,JE Moulder and Z Lazarova1J Invest Dermatol 131: S138 |
25. Effect of ionizing radiation on combined skin and wound injury. A Lopez, EB Olasz, JE Moulder, SR Doctrow, Z Lazarova. AFRI 2012 Bethesda |
26. Effect of ionizing radiation on combined skin and wound injury. A Lopez, MM Jourdan, A Schock, N Duncan, EB Olasz, JE Moulder, BL Fish, SR Doctrow, Z Lazarova. Radiation Research Society Annual Meeting, 2012, Puerto Rico |
27. MicroRNAs signatures in cutaneous squamous cell carcinomas of immunocompetent and organ transplant patients. EB Olasz,M Neuburg,J Lazar,NE Duncan,AM Schock,L Seline,A Lopez,Y Lu,P Liu nd Z Lazarova1J Invest Dermatol 132: S21 |
28. MicroRNA signitures in cutaneous squamous cell carcinoma of immunocompetent and organ transplant patients. EB Olasz, M Neuburg, J Lazar, NE Duncan, AM Schock, L Seline, A Lopez, Y Lu, P Liu, Z Lazarova. International Transplant Skin Cancer Collaborative Annual Meeting 2012, Essex, MA |
29. Expression of epidermal growth factor receptor and detection of mutant EGFR (EGFRvIII) in human cutaneous squamous cell carcinoma. PJ Dziunycz,Z Lazarova,N Duncan,S Wong,M Neuburg,GF Hofbauer and EB Olasz J Invest Dermatol 133: S75 |
30. 2022 Unique clinical and histopathologic presentations of Merkel Cell Carcinoma (MCC) in renal transplant recipients
Sabrina Popatia MD MPH, Edit Olasz Harken MD PhD, Karolyn A. Wanat MD, Kara Young MD, Callisia Clarke, MD, Stuart Wong, MD, Amy Harker-Murray MD, Monica Shukla MD, Musaddiq Awan MD, Julia Kasprzak MD
|
